Lauren Massaro

Catch up on important diabetes news from the month of August.

Stephanie Sober, MD, MSHP, investigator on the pivotal research that supported the prescription-to-OTC switch of Opill, shares insights on how the medicine is reshaping the reproductive landscape.

Don’t miss out on the latest pharmacy insights in the Drug Topics July/August issue.

The government said the tests will “detect current COVID-19 variants and can be used through the end of the year.”

“While seasonal variation exists, it is expected that seniors will continue to benefit from flu vaccines that are stronger than the traditional standard-dose vaccines,” wrote investigators.

In case you missed it, this week we had news about illegal online GLP-1 sales, pharmacy deserts, innovative medication cooling technologies, and more.

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

Access inequities are preventing the US-affiliated Pacific Island (USAPI) jurisdictions from meeting the WHO 2030 goal of 90% human papillomavirus (HPV) vaccination series completion coverage.

A detailed report of study findings will be published in a peer-reviewed journal and presented at ObesityWeek 2024.

FDA approval of Amneal Pharmaceuticals' propofol injectable emulsion single-dose vials aims to address the drug’s history of chronic supply issues.

Final approval of the therapy may occur after expiration of the 3-year regulatory exclusivity for Tyvaso DPI on May 23, 2025.

Participants were asked to rate their level of concern on 26 health topics.

In case you missed it, this week we had news about digital therapeutics for depression, bracing for fall allergies, at-home tests for sexually transmitted infections, and more.

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

First To Know Syphilis Tests are expected to be available at major national retailers and online in late 2024.

A CDC report called for “increased efforts” to ensure parents can obtain all recommended vaccines for their eligible children and realize the full potential of the VFC program.

TAK-003 could be a powerful combatant against the increasing global threat of dengue virus.

In case you missed it, this week we had news about opioid prescribing for patients with chronic pain, a possible link between cannabis and cancer, preparing for the upcoming flu season, and more.

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

The epinephrine nasal spray from ARS Pharmaceuticals has become the first and only needle-free epinephrine alternative and the first new delivery method for epinephrine in over 3 decades.

See what’s trending in pharmacy with a preview of the Drug Topics July/August issue.

In a clinical trial, IPX203 was able to achieve longer good on-time with less doses compared to standard treatment.

Mark Garofoli delves deeper into the challenges men face when it comes to acknowledging pain, underscoring the critical need to dismantle the surrounding stigma.

Make every month a celebration of wellbeing at the pharmacy by leveraging disease awareness initiatives.

In a recent conversation with Drug Topics on Over the Counter, Mark Garofoli discusses why men avoid seeking medical help for pain, as well as potential solutions.

In case you missed it, this week we had news about CVS in the spotlight of PBM reform, landmark FDA approvals in synovial sarcoma, liraglutide for dementia, and more.

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

Afami-cel is the first new treatment for synovial sarcoma in more than 10 years, ending a long-standing therapeutic gap.

Pharmacists should be knowledgeable about the symptoms of chemical peel irritation to effectively advise patients.

Anisha Patel, PharmD, a pharmacist turned podcast host, shares insights on leveraging all the opportunities pharmacy has to offer to build a diverse and rewarding career.